US Stock MarketDetailed Quotes
AEON AEON Biopharma
- 0.544
- +0.009+1.61%
Close Nov 29 13:00 ET
- 0.557
- +0.013+2.45%
Post 16:31 ET
21.74MMarket Cap1.58P/E (TTM)
0.562High0.540Low112.10KVolume0.562Open0.535Pre Close61.67KTurnover0.79%Turnover RatioLossP/E (Static)39.97MShares17.17052wk High-0.68P/B7.77MFloat Cap0.52152wk Low--Dividend TTM14.28MShs Float17.170Historical High--Div YieldTTM4.15%Amplitude0.521Historical Low0.550Avg Price1Lot Size
AEON Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating revenue | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 4.02M | -44.46%7.76M | -20.43%10.38M | 13.97M | 13.05M | 31.31%48.43M | 15.03M | 9.91M | 95.08%36.88M | |
| Selling and administrative expenses | --3.04M | -32.85%3.32M | 21.04%4.65M | ---- | --4.95M | --3.84M | 22.61%13.68M | --5.5M | --2.44M | -3.75%11.15M |
| Research and development costs | --972K | -50.81%4.44M | -37.73%5.73M | ---- | --9.03M | --9.21M | 35.08%34.75M | --9.53M | --7.48M | 251.52%25.73M |
| Operating profit | -4.02M | 44.46%-7.76M | 20.43%-10.38M | -13.97M | -13.05M | -31.31%-48.43M | -15.03M | -9.91M | -125.05%-36.88M | |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -2.16M | 12,306.82%171.87M | -2,243.50%-107.64M | -1.41M | -4.59M | 78.00%-4.13M | -19.53M | -525K | -13.60%-18.76M | |
| Gain on sale of security | ---296K | --8.81M | ---43.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | --161.23M | ---63.77M | ---- | --0 | --0 | --0 | --0 | --0 | -160.91%-28.97M |
| -Less：Restructuring and merger&acquisition | --0 | ---161.23M | --63.77M | ---- | --0 | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 160.91%28.97M |
| Other non- operating income (expenses) | ---1.86M | 229.90%1.83M | 98.95%-48K | ---- | ---1.41M | ---4.59M | -140.42%-4.13M | ---19.53M | ---525K | 281.87%10.21M |
| Income before tax | -6.17M | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net income | -6.17M | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | |
| Net income continuous Operations | ---6.17M | 1,167.12%164.11M | -569.07%-118.02M | ---- | ---15.38M | ---17.64M | 5.54%-52.56M | ---34.56M | ---10.44M | -69.04%-55.64M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -6.17M | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -6.17M | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -102.73%-55.64M | |
| Basic earnings per share | -0.17 | 852.70%4.22 | -295.30%-3.17 | -0.5606 | -0.8019 | 5.54%-2.3893 | -1.5713 | -0.4745 | -36.72%-2.5294 | |
| Diluted earnings per share | -0.24 | 852.70%4.22 | -295.30%-3.17 | -0.5606 | -0.8019 | 5.54%-2.3893 | -1.5713 | -0.4745 | -36.72%-2.5294 | |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data